| Winters Healthcare Clinic | |
|
172 E Grant Ave Winters CA 95694-1780 | |
| (530) 795-4377 | |
| (530) 795-9541 |
| Full Name | Winters Healthcare Clinic |
|---|---|
| Speciality | Clinic/Center |
| Location | 172 E Grant Ave, Winters, California |
| Authorized Official Name and Position | Christopher Kelsch (EXECUTIVE DIRECTOR) |
| Authorized Official Contact | 5307954377 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Winters Healthcare Clinic 172 E Grant Ave Winters CA 95694-1780 Ph: (530) 795-4377 | Winters Healthcare Clinic 172 E Grant Ave Winters CA 95694-1780 Ph: (530) 795-4377 |
| NPI Number | 1992736086 |
|---|---|
| Provider Enumeration Date | 07/06/2006 |
| Last Update Date | 08/19/2020 |
| Medicare PECOS PAC ID | 2567490238 |
|---|---|
| Medicare Enrollment ID | O20050803000213 |
News Archive
A Colorado School of Public Health researcher has found that laws designed to illuminate financial links between doctors and pharmaceutical companies have little or no effect on what drugs physicians prescribe.
Solta Medical, Inc., a global leader in the medical aesthetics market, today announced that it has received the Provectus Award presented by MDB Capital Group at the first annual Bright Lights Conference, the first public company conference to focus exclusively on companies with disruptive and market changing intellectual property (IP).
A recent report by the Institute of Medicine (IOM) confirmed that 3.5 to 5.3 million people (1-2 % of the U.S. population) have chronic hepatitis B virus (HBV) or hepatitis C virus (HCV) infections. Despite efforts by federal, state and local government agencies to control and prevent these diseases, they remain a serious public health concern. The major factor impeding efforts to control HBV and HCV is lack of knowledge and awareness among health care providers, social service professionals, members of the public, and policy-makers.
Xinyuan Chen, an assistant professor of biomedical and pharmaceutical sciences, joined URI's College of Pharmacy after seven years at Massachusetts General Hospital in Boston, bringing with him a $1.08 million career development grant from the National Institute of Drug Abuse and a $432,000 grant from the National Institute of Allergy and Infectious Disease.
› Verified 7 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1992736086 | NPI | - | NPPES |
| 030000787 | Other | CA | STATE LICENSE |
| HAP71037F | Medicaid | CA | |
| ZZZ04589Z | Other | CA | MEDICARE PTAN |
| 2254671 | Other | CA | STATE CORPORATION NUMBER |
| BCP71037F | Medicaid | CA | |
| FHC71037F | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261QF0400X | Clinic/center - Federally Qualified Health Center (fqhc) | (* (Not Available)) | Primary |
News Archive
A Colorado School of Public Health researcher has found that laws designed to illuminate financial links between doctors and pharmaceutical companies have little or no effect on what drugs physicians prescribe.
Solta Medical, Inc., a global leader in the medical aesthetics market, today announced that it has received the Provectus Award presented by MDB Capital Group at the first annual Bright Lights Conference, the first public company conference to focus exclusively on companies with disruptive and market changing intellectual property (IP).
A recent report by the Institute of Medicine (IOM) confirmed that 3.5 to 5.3 million people (1-2 % of the U.S. population) have chronic hepatitis B virus (HBV) or hepatitis C virus (HCV) infections. Despite efforts by federal, state and local government agencies to control and prevent these diseases, they remain a serious public health concern. The major factor impeding efforts to control HBV and HCV is lack of knowledge and awareness among health care providers, social service professionals, members of the public, and policy-makers.
Xinyuan Chen, an assistant professor of biomedical and pharmaceutical sciences, joined URI's College of Pharmacy after seven years at Massachusetts General Hospital in Boston, bringing with him a $1.08 million career development grant from the National Institute of Drug Abuse and a $432,000 grant from the National Institute of Allergy and Infectious Disease.
› Verified 7 days ago